Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01619358
What this trial is testing

Genomic-Based Diagnosis, Classification and Targeted Treatment of Multiple Myeloma

Who this might be right for
Multiple Myeloma
National University Hospital, Singapore 150
Not applicableNot Yet RecruitingNCT07383415
What this trial is testing

Intranasal Platelet-Rich Plasma With or Without Topical Insulin for Post-Inflammatory Anosmia

Who this might be right for
AnosmiaInflammatory Anosmia
Amin Javer 20
Not applicableLooking for participantsNCT06279026
What this trial is testing

UTAA17 Injection in the Treatment of Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 15
Large-scale testing (Phase 3)Ended earlyNCT00967343
What this trial is testing

Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor

Who this might be right for
Myeloid LeukemiaLymphoblastic LeukemiaLymphoma+3 more
Kiadis Pharma 40
Large-scale testing (Phase 3)Study completedNCT04362176
What this trial is testing

Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults

Who this might be right for
COVID-19CoronavirusSARS-CoV-2
Vanderbilt University Medical Center 974
Testing effectiveness (Phase 2)UnknownNCT05914662
What this trial is testing

Zanubrutinib Plus BR in Newly Diagnosed Symptomatic WM

Who this might be right for
Waldenstrom Macroglobulinemia
Institute of Hematology & Blood Diseases Hospital, China 42
Testing effectiveness (Phase 2)Study completedNCT03267888
What this trial is testing

Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
ISS Stage I Plasma Cell MyelomaISS Stage II Plasma Cell MyelomaISS Stage III Plasma Cell Myeloma+2 more
Emory University 25
Testing effectiveness (Phase 2)Looking for participantsNCT02343042
What this trial is testing

Selinexor and Backbone Treatments of Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Karyopharm Therapeutics Inc 300
Early research (Phase 1)Not Yet RecruitingNCT07679919
What this trial is testing

BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Hematologic Malignancies

Who this might be right for
Non-Hodgkin LymphomaChronic Lymphocytic LeukemiaHairy Cell Leukemia+1 more
Luminary Therapeutics 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT06550895
What this trial is testing

Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 11
Not applicableLooking for participantsNCT07609576
What this trial is testing

Infectious Complications in Hematological Patients Under Treatment With Bispecific Antibodies.

Who this might be right for
Lymphoma NeoplasmsMyeloma MultipleSevere Infection+3 more
Infanta Leonor University Hospital 350
Large-scale testing (Phase 3)Looking for participantsNCT03937635
What this trial is testing

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Who this might be right for
Smoldering Plasma Cell Myeloma
ECOG-ACRIN Cancer Research Group 288
Testing effectiveness (Phase 2)Study completedNCT00003401
What this trial is testing

Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Maryland, Baltimore
Not applicableUnknownNCT03586557
What this trial is testing

Effectiveness of Plasma Exchange in Treating With Severe Acute AQP4-Ab Positive Optic Neuritis

Who this might be right for
Optic Neuritis
Chinese PLA General Hospital 142
Early research (Phase 1)Not Yet RecruitingNCT07169565
What this trial is testing

Ibrutinib Followed by BR (Bendamustine and Rituximab) as a Time-Limited Therapy for Waldenström Macroglobulinemia

Who this might be right for
Waldenström Macroglobulinemia (WM)
Institute of Hematology & Blood Diseases Hospital, China 21
Testing effectiveness (Phase 2)Study completedNCT07306611
What this trial is testing

Regenerative Treatment of Female Genital Atrophy

Who this might be right for
Vulvo Vaginal Atrophy
AndreiaAntunes 30
Not applicableStudy completedNCT01855698
What this trial is testing

PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism

Who this might be right for
Hematologic NeoplasmAcute LeukemiaMyelodysplastic Syndrome+2 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 99
Testing effectiveness (Phase 2)Study completedNCT00872521
What this trial is testing

Efficacy of Treatment With Bortezomib (in Combination With Doxorubicin and Dexamethasone) in Previously Untreated Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen-Cilag Pty Ltd 107
Large-scale testing (Phase 3)Study completedNCT01233258
What this trial is testing

A Trial to Compare Prophylaxis Therapy to On-demand Therapy With a New Full Length Recombinant FVIII in Patients With Severe Hemophilia A

Who this might be right for
Hemophilia A
Bayer 80
Early research (Phase 1)Study completedNCT04057872
What this trial is testing

Therapeutic Plasma Exchange in Adult Patients With Severe Sepsis

Who this might be right for
Septic Shock
Alberta Health Services, Calgary 17
Next Page